You are here » Home » Company » Natco Pharma Ltd

Natco Pharma Ltd.

BSE: 524816 Sector: Health care
NSE: NATCOPHARM ISIN Code: INE987B01026
BSE 00:00 | 21 Sep 788.10 10.70
(1.38%)
OPEN

780.00

HIGH

795.00

LOW

755.00

NSE 00:00 | 21 Sep 790.05 15.05
(1.94%)
OPEN

785.00

HIGH

796.60

LOW

751.05

OPEN 780.00
PREVIOUS CLOSE 777.40
VOLUME 21018
52-Week high 1061.95
52-Week low 698.85
P/E 18.42
Mkt Cap.(Rs cr) 14,540
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 780.00
CLOSE 777.40
VOLUME 21018
52-Week high 1061.95
52-Week low 698.85
P/E 18.42
Mkt Cap.(Rs cr) 14,540
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Natco Pharma Ltd.

Natco Pharma Ltd

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The company's focus is primarily on niche therapeutic areas and complex products. The company sells its products in over 40 countries. FDF products are sold in the United States I...> More

Natco Pharma Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   14,540
EPS - TTM () [*S] 42.79
P/E Ratio (X) [*S] 18.42
Face Value ()   2
Latest Dividend (%)   75.00
Latest Dividend Date 20 Aug 2018
Dividend Yield (%) 1.05
Book Value / Share () [*S] 169.40
P/B Ratio () [*S] 4.65
[*C] Consolidated     [*S] Standalone    

Natco Pharma Ltd - Financial Results

Particulars ( cr) Jun 2018 Jun 2017 % Chg
Net Sales 538.6 428.1 25.81
Other Income 35.9 3.4 955.88
Total Income 574.5 431.5 33.14
Total Expenses 321 291.4 10.16
Operating Profit 253.5 140.1 80.94
Net Profit 181.1 93.7 93.28
Equity Capital 36.9 34.9 -
> More on Natco Pharma Ltd Financials Results

Natco Pharma Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Glenmark Pharma. 655.15 -2.13 18488.33
Abbott India 8233.20 -2.23 17495.55
Sanofi India 6487.60 2.57 14940.94
Natco Pharma 788.10 1.38 14540.45
Pfizer 3143.45 0.97 14381.28
Syngene Intl. 642.20 2.82 12844.00
Alembic Pharma 648.90 1.60 12231.77
> More on Natco Pharma Ltd Peer Group

Natco Pharma Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 48.37
Banks/FIs 0.65
FIIs 24.39
Insurance 0.00
Mutual Funds 5.37
Indian Public 17.19
Custodians 0.00
Other 3.78
> More on Natco Pharma Ltd Share Holding Pattern

Natco Pharma Ltd - Research Reports

Date Broker Action Price Report
07/11 Equirus Securities Accumulate 957 PDF IconDetails
> More on Natco Pharma Ltd Research Reports

Natco Pharma Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -4.50% -4.38% -3.28% -3.23%
1 Month 3.70% 3.99% -3.77% -3.70%
3 Month -2.02% -2.09% 3.98% 3.74%
6 Month 0.86% 1.02% 11.18% 9.73%
1 Year -2.03% -1.97% 13.81% 10.09%
3 Year 74.07% 75.13% 40.65% 39.69%

Natco Pharma Ltd - STOCK STRENGTH

Today's Low/High 755.00
795.00
Week Low/High 755.00
838.00
Month Low/High 749.45
849.00
YEAR Low/High 698.85
1062.00
All TIME Low/High 1.60
1080.00